COMMUNIQUÉS West-GlobeNewswire

Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018
12/02/2018
DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) will host a conference call on Thursday, February 15, 2018 at 4:30 p.m. EST to discuss fourth quarter and full year 2017 [...]
Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call
12/02/2018
ROCKVILLE, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML
12/02/2018
• Conference call to be held on Tuesday, February 13 th , 2018 at 4:30 PM ET to discuss planned Phase 1 clinical trial with Dr. Ehab Atallah • New trial represents expansion of Actinium’s CD33 program and increases [...]
K2M Group Holdings, Inc. to Participate in the 2018 RBC Capital Markets Global Healthcare Conference
12/02/2018
LEESBURG, Va., Feb. 12, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Affimed Announces Proposed Public Offering of Common Stock
12/02/2018
Heidelberg, Germany February 12, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has [...]
NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences’ Board of Directors
12/02/2018
CAMBRIDGE, Mass., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Ali Behbahani, M.D., a partner in [...]
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced that it intends to offer and sell shares of its common stock in an underwritten public [...]
Adverum Biotechnologies Announces Closing of $69 Million Public Offering
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Onconova Therapeutics Announces Closing of $10 Million Underwritten Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Securities
12/02/2018
NEWTOWN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Franciscan Alliance, Circulation Unveil Non-Emergency Transportation Partnership
12/02/2018
MISHAWAKA, Indiana, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Hospital patients with ongoing medical conditions often are unable to receive the care they need because they don’t have transportation to see their doctors or make [...]
CROSSJECT :Information relative au nombre total de droits de vote et d'actions composant le capital social
12/02/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 12 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Athersys to Host Year-End 2017 Financial Results Call
12/02/2018
CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX ) will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018, and will host a conference [...]
CROSSJECT :ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS (BSA) ET RENFORCEMENT DE SES FONDS PROPRES PAR UNE ÉMISSION OBLIGATAIRE CONVERTIBLE D'UN MONTANT DE 5,250 M€
12/02/2018
Communiqué de Presse CROSSJECT ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS (BSA) AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET LE RENFORCEMENT DE SES FONDS PROPRES PAR UNE ÉMISSION OBLIGATAIRE [...]
Bionano Genomics Announces Global Launch of its New Direct Labeling Chemistry for Genome Mapping and Structural Variation Analysis
12/02/2018
Direct Labeling chemistry provides chromosome arm length maps and improves SV detection resolution down to 500 bp for as little as $500 per genome To be showcased at the AGBT General Meeting this week SAN DIEGO, Feb. 12 [...]
Sanofi: Disclosure of trading in own shares
12/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/c0c53934-7270-4d20-990d-48714cfcded3
Sanofi : Déclaration des transactions sur actions propres
12/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/107c7dc4-5d1a-4365-9889-5947e1b6cce7
Ossur Hf : Transactions in relation to share buyback program
12/02/2018
Announcement from Össur hf. No. 9/2018 Reykjavík, 12 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
CyberFuels Inc. gains approval for EcoFlex 96 to be sold in Texas and plans to acquire Texas Bulk Fuel Distributor
12/02/2018
PALM BEACH, Fla., Feb. 12, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ESCL) is pleased to announce that its wholly owned subsidiary, CyberFuels Inc. will begin selling its EcoFlex 96 fuel in Texas. Under the [...]
Precision Imaging Centers Implements eRAD RIS, Portals, and RADAR
12/02/2018
GREENVILLE, S.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- eRAD, a subsidiary of RadNet, Inc., a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Precision [...]

Pages